NeuroPace (NPCE) Current Deferred Revenue (2023 - 2026)
NeuroPace (NPCE) recorded Current Deferred Revenue of $120,000 in Q3 2026, down 81.5% from $649,000 a year earlier and down 2.4% from the prior quarter.
Powered by 
Analysis
NeuroPace (NPCE) Current Deferred Revenue (2023 - 2026) Analysis & Trends
At the end of FY2025, NeuroPace reported Current Deferred Revenue of $141,000, down 76.5% from FY2024.
- Across earlier years, Current Deferred Revenue came in at $600,000 in FY2024 (-45.5%) and $1.1 million in FY2023.
- The Q3 2026 figure is the lowest quarterly Current Deferred Revenue in data going back to Q4 2023.
- On a year-over-year basis, Current Deferred Revenue has declined for eight consecutive quarters, with an average decline of 52.1% over the last eight quarters.
- The year-over-year decline in Current Deferred Revenue has ranged between 13.4% (Q3 2025) and 82.4% (Q2 2026) over the last five years.
- Per Business Quant, the preceding three quarters came in at $123,000 (Q2 2026), $126,000 (Q1 2026) and $141,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.44 Bn | 236.08 Bn | 5.13 Bn |
| 2 | Abbott Laboratories | 187.98 Bn | 162.45 Bn | 7.39 Bn |
| 3 | Danaher | 163.91 Bn | 143.58 Bn | 3.84 Bn |
| 4 | Intuitive Surgical | 153.75 Bn | 134.17 Bn | 2.08 Bn |
| 5 | Medtronic | 131.67 Bn | 97.80 Bn | 6.34 Bn |
| 6 | Stryker | 117.84 Bn | 104.03 Bn | 4.25 Bn |
| 7 | Boston Scientific | 64.27 Bn | 59.95 Bn | 3.43 Bn |
| 8 | Edwards Lifesciences | 61.69 Bn | 45.00 Bn | 1.35 Bn |
| 9 | Medline | 51.94 Bn | 49.07 Bn | 1.93 Bn |
| 10 | NeuroPace | 260.31 Mn | 44.34 Mn | 19.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 120,000.00 |
| Jun 30, 2026 | 123,000.00 |
| Mar 31, 2026 | 126,000.00 |
| Dec 31, 2025 | 141,000.00 |
| Sep 30, 2025 | 649,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 749,000.00 |
| Jun 30, 2024 | 809,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Dec 31, 2023 | 1.10 Mn |
API Access
NeuroPace Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NPCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "NPCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NPCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();